{
    "charts": [
        {"name": "Breast Cancer", "chart": [
            {"node": "Neoadjuvant", "tree": [
                {"branch": "HER2+", "subBranches": [
                    {"branch": "Early Breast Cancer", "subBranches": [
                        {"branch": "trial", "trial": "ROCHE WO40324/Federica", "rn": "Ann", "recruitment": "closed"}
                    ]}
                ]},
                {"branch": "HER2-", "subBranches": [
                ]}
            ]},
            {"node": "Adjuvant", "tree": [
                {"branch": "HER2+", "subBranches": [
                ]},
                {"branch": "HER2-", "subBranches": [
                    {"branch": "Hormone Receptor Positive", "subBranches": [
                        {"branch": "Early Breast Cancer", "subBranches": [
                            {"branch": "trial", "trial": "Novartis CLEE011012301C NATALEE/TRIO033", "rn": "Shannon", "recruitment": "open"}
                        ]}
                    ]} 
                ]}
            ]},
            {"node": "Metastatic", "tree": [
                {"branch": "Triple Negative or HER2+", "subBranches": [
                ]}
            ]},
            {"node": "Second Line", "tree": [
            ]},
            {"node": "Other", "tree": [
                {"branch": "High Risk for Chemo Induced Nausea and Vomiting", "subBranches": [
                    {"branch": "trial", "trial": "OHRI The ILIAD study", "rn": "Virginia", "recruitment": "closed"}
                ]}
            ]},
            {"node": "Basket Study", "tree": [
                {"branch": "Adjuvant, First, Second, Third Line", "subBranches": [
                    {"branch": "Over 70", "subBranches": [
                        {"branch": "trial", "trial": "The 5C Study", "rn": "Tammy", "recruitment": "open"}
                    ]}
                ]}
            ]}
        ]},
        {"name": "Genito-Urinary", "chart":[
            {"node": "Renal Cell Carcinoma", "tree": [
                {"branch": "Adjuvant", "subBranches": [
                    {"branch": "Post Nephrectomy", "subBranches": [
                        {"branch": "trial", "trial": "MERCK MK3475-564 / KEYNOTE-564", "rn": "Tammy", "recruitment": "closed"}
                    ]},
                    {"branch": "Localized", "subBranches": [
                        {"branch": "High Risk of Relapse post partial/radical nephrectomy", "subBranches": [
                            {"branch": "trial", "trial": "BMS CA209-914", "rn": "Divina", "recruitment": "open"}
                        ]}
                    ]}
                ]},
                {"branch": "Line 1-2-3", "subBranches": [
                    {"branch": "Advanced Renal Cell Carcinoma", "subBranches": [
                        {"branch": "trial", "trial": "BMS CA018005 / FRACTION-RCC", "rn": "Lynn", "recruitment": "open"}
                    ]}
                ]}
            ]},
            {"node": "Prostate", "tree": [
                {"branch": "Adjuvant", "subBranches": [
                ]},
                {"branch": "Metastatic", "subBranches": [
                    {"branch": "Hormone Sensitive", "subBranches": [
                        {"branch": "First Line", "subBranches": [
                        ]},
                        {"branch": "Second Line", "subBranches": [
                        ]},
                        {"branch": "Third Line", "subBranches": [
                        ]}
                    ]},
                    {"branch": "Castrate Resistant", "subBranches": [
                        {"branch": "First Line", "subBranches": [
                            {"branch": "Chemotherapy Na√Øve; progressed on NG Hormonal Agent", "subBranches": [
                                {"branch": "trial", "trial": "Merck MK3475-641 / KEYNOTE 641", "rn": "Lynn", "recruitment": "open"}
                            ]},
                            {"branch": "trial", "trial": "Merck MK3475-921 / KEYNOTE 921", "rn": "Lynn", "recruitment": "open"}
                        ]},
                        {"branch": "Second Line", "subBranches": [
                            {"branch": "Associated Homologous Recombination Deficiency", "subBranches": [
                                {"branch": "trial", "trial": "(Clovis) TRITON 3/CO-338-063", "rn": "Sam", "recruitment": "open"}
                            ]}
                        ]},
                        {"branch": "Third Line", "subBranches": [
                            {"branch": "Associated Homologous Recombination Deficiency", "subBranches": [
                                {"branch": "trial", "trial": "(Clovis) TRITON 3/CO-338-063", "rn": "Sam", "recruitment": "open"}
                            ]}
                        ]}
                    ]}
                ]}
            ]},
            {"node": "Bladder Cancer", "tree": [
                {"branch": "Cisplatineligible, MuscleInvasive", "subBranches": [
                    {"branch": "Neoadjuvant", "subBranches": [
                    ]}
                ]},
                {"branch": "Locally Advanced or Mets Urothelial", "subBranches": [
                    {"branch": "First Line", "subBranches": [
                        {"branch": "trial", "trial": "(Merck) MK-7902-011", "rn": "Divina", "recruitment": "open"}
                    ]},
                    {"branch": "Third Line", "subBranches": [
                        {"branch": "trial", "trial": "(ASTELLAS) 7465-CL-0301", "rn": "Marianna", "recruitment": "open"}
                    ]}
                ]}
            ]},
            {"node":"Basket Study", "tree": [
                {"branch": "Adjuvant, First, Second, Third Line", "subBranches": [
                    {"branch": "Over 70", "subBranches": [
                        {"branch": "trial", "trial": "The 5C Study", "rn": "Tammy", "recruitment": "open"}
                    ]}
                ]}
            ]}
        ]},
        {"name": "Cutaneous Oncology", "chart": [
            {"node": "Melanoma", "tree": [
                {"branch": "Resectable", "subBranches": [
                    {"branch": "First Line", "subBranches": [
                    ]},
                    {"branch": "Second Line", "subBranches": [
                    ]},
                    {"branch": "Third Line", "subBranches": [
                    ]}
                ]},
                {"branch": "Unresectable", "subBranches": [
                    {"branch": "First Line", "subBranches": [
                    ]},
                    {"branch": "Second Line", "subBranches": [
                    ]},
                    {"branch": "Third Line", "subBranches": [
                    ]},
                    {"branch": "Metastatic", "subBranches": [
                        {"branch": "trial", "trial": "(CCTG) ME:13/STOP-GAP", "rn": "Divina", "recruitment": "open"}
                    ]}
                ]}
            ]},
            {"node":"Basket Study", "tree": [
                {"branch": "Adjuvant, First, Second, Third Line", "subBranches": [
                    {"branch": "Over 70", "subBranches": [
                        {"branch": "trial", "trial": "The 5C Study", "rn": "Tammy", "recruitment": "open"}
                    ]}
                ]}
            ]}
        ]},
        {"name": "Lung Cancer", "chart": [
            {"node": "Small Cell (SCLC)", "tree": [
                {"branch": "Limited", "subBranches": [
                ]},
                {"branch": "Extensive", "subBranches": [
                    {"branch": "Maintenance", "subBranches": [
                        {"branch": "trial", "trial": "(ABBVIE) M16-298 / MERU)", "rn": "Marianna", "recruitment": "closed"}
                    ]}
                ]}
            ]},
            {"node": "Non-small Cell (NSLSC)", "tree": [
                {"branch": "Resectable", "subBranches": [
                    {"branch": "Adjuvant Therapy", "subBranches": [
                        {"branch": "trial", "trial": "(CCTG) BR.31", "rn":"Marianna", "recruitment": "open"}
                    ]}
                ]},
                {"branch": "Unresctable", "subBranches": [
                    {"branch": "First Line", "subBranches": [
                        {"branch": "trial", "trial": "(ROCHE) BO29554/BFAST", "rn": "Sam", "recruitment": "open"}
                    ]},
                    {"branch": "Second Line", "subBranches": [
                        {"branch": "trial", "trial": "BMS CA209-907", "rn": "not assigned", "recruitment": "closed"}
                    ]},
                    {"branch": "Third Line", "subBranches": [
                    ]}
                ]}
            ]},
            {"node":"Basket Study", "tree": [
                {"branch": "Adjuvant, First, Second, Third Line", "subBranches": [
                    {"branch": "Over 70", "subBranches": [
                        {"branch": "trial", "trial": "The 5C Study", "rn": "Tammy", "recruitment": "open"}
                    ]}
                ]}
            ]}
        ]}
    ]
}